Oppenheimer & Co’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,259
Closed -$48K 1448
2022
Q2
$48K Sell
4,259
-1,065
-20% -$12K ﹤0.01% 1366
2022
Q1
$159K Sell
5,324
-356
-6% -$10.6K ﹤0.01% 1385
2021
Q4
$151K Sell
5,680
-459
-7% -$12.2K ﹤0.01% 1426
2021
Q3
$223K Sell
6,139
-20,057
-77% -$729K ﹤0.01% 1354
2021
Q2
$1.14M Buy
26,196
+19,774
+308% +$858K 0.02% 698
2021
Q1
$220K Sell
6,422
-114
-2% -$3.91K ﹤0.01% 1313
2020
Q4
$229K Sell
6,536
-11
-0.2% -$385 ﹤0.01% 1195
2020
Q3
$157K Sell
6,547
-115
-2% -$2.76K ﹤0.01% 1192
2020
Q2
$122K Buy
6,662
+100
+2% +$1.83K ﹤0.01% 1190
2020
Q1
$102K Sell
6,562
-70
-1% -$1.09K ﹤0.01% 1117
2019
Q4
$142K Sell
6,632
-174
-3% -$3.73K ﹤0.01% 1220
2019
Q3
$127K Sell
6,806
-464
-6% -$8.66K ﹤0.01% 1201
2019
Q2
$190K Sell
7,270
-205
-3% -$5.36K 0.01% 1197
2019
Q1
$192K Sell
7,475
-230
-3% -$5.91K 0.01% 1232
2018
Q4
$177K Hold
7,705
0.01% 1123
2018
Q3
$247K Buy
7,705
+275
+4% +$8.82K 0.01% 1143
2018
Q2
$210K Sell
7,430
-384
-5% -$10.9K 0.01% 1204
2018
Q1
$277K Sell
7,814
-207
-3% -$7.34K 0.01% 1100
2017
Q4
$311K Sell
8,021
-2
-0% -$78 0.01% 1038
2017
Q3
$204K Sell
8,023
-201
-2% -$5.11K 0.01% 1183
2017
Q2
$225K Sell
8,224
-6
-0.1% -$164 0.01% 1129
2017
Q1
$272K Sell
8,230
-46
-0.6% -$1.52K 0.01% 1031
2016
Q4
$197K Sell
8,276
-33
-0.4% -$786 0.01% 1163
2016
Q3
$305K Sell
8,309
-367
-4% -$13.5K 0.01% 979
2016
Q2
$193K Sell
8,676
-601
-6% -$13.4K 0.01% 1104
2016
Q1
$193K Buy
9,277
+42
+0.5% +$874 0.01% 1105
2015
Q4
$280K Sell
9,235
-438
-5% -$13.3K 0.01% 981
2015
Q3
$239K Sell
9,673
-8
-0.1% -$198 0.01% 1085
2015
Q2
$311K Buy
9,681
+289
+3% +$9.28K 0.01% 1079
2015
Q1
$335K Buy
+9,392
New +$335K 0.01% 1058
2013
Q4
Sell
-2,000
Closed -$72K 1447
2013
Q3
$72K Sell
2,000
-70
-3% -$2.52K ﹤0.01% 1265
2013
Q2
$69K Buy
+2,070
New +$69K ﹤0.01% 1224